Wall Street debates the Fed's next move as tariff and inflation uncertainty mount ahead of this week's CPI report.

Tariffs have again become the center of global investing conversation, and they are biting deeper this time, with the U.S.

Arvinas PROTAC protein degraders have some potential, with vepdegestrant as its late-stage, most promising asset, partnered ...

Anthony Albanese is making the case for Australian iron ore in China as steelmakers stare down challenges in an increasingly ...